BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16455206)

  • 1. Botulinum toxin: a novel therapeutic option for bronchial asthma?
    Lim EC; Ong BK; Oh VM; Seet RC
    Med Hypotheses; 2006; 66(5):915-9. PubMed ID: 16455206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provoked models of asthma: what have we learnt?
    O'Byrne PM; Gauvreau GM; Brannan JD
    Clin Exp Allergy; 2009 Feb; 39(2):181-92. PubMed ID: 19187330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods used in clinical development of novel anti-asthma therapies.
    Diamant Z; Boot D; Kamerling I; Bjermer L
    Respir Med; 2008 Mar; 102(3):332-8. PubMed ID: 18061420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin injections to reduce adiposity: possibility, or fat chance?
    Lim EC; Seet RC
    Med Hypotheses; 2006; 67(5):1086-9. PubMed ID: 16716533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data.
    Ateş Y
    Agri; 2006 Jul; 18(3):5-11. PubMed ID: 17089224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.
    Elekes K; Helyes Z; Kereskai L; Sándor K; Pintér E; Pozsgai G; Tékus V; Bánvölgyi A; Németh J; Szuts T; Kéri G; Szolcsányi J
    Eur J Pharmacol; 2008 Jan; 578(2-3):313-22. PubMed ID: 17961545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y;
    Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.
    Gracies JM; Singer BJ; Dunne JW
    Disabil Rehabil; 2007 Dec; 29(23):1789-805. PubMed ID: 18033604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-organized patchiness in asthma as a prelude to catastrophic shifts.
    Venegas JG; Winkler T; Musch G; Vidal Melo MF; Layfield D; Tgavalekos N; Fischman AJ; Callahan RJ; Bellani G; Harris RS
    Nature; 2005 Apr; 434(7034):777-82. PubMed ID: 15772676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial epilepsy or broncho-pulmonary hyper-excitability as a model of asthma pathogenesis.
    Hoang BX; Levine SA; Graeme Shaw D; Pham P; Hoang C
    Med Hypotheses; 2006; 67(5):1042-51. PubMed ID: 16797869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where has all the botox gone? (how) will we ever learn... using monoclonal antibodies to track botulinum toxin.
    Lim EC; Oh VM; Ong BK; Chow AW; Seet RC
    Med Hypotheses; 2006; 67(3):440-6. PubMed ID: 16678355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternations of bronchial smooth muscle and effect of therapy on remodeling in asthma].
    Pałgan K; Dziedziczko A; Bartuzi Z
    Pol Merkur Lekarski; 2006 Jul; 21(121):5-7. PubMed ID: 17007282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin, Quo Vadis?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(4):718-23. PubMed ID: 17499937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine in the airways: implications and applications.
    Spicuzza L; Di Maria G; Polosa R
    Eur J Pharmacol; 2006 Mar; 533(1-3):77-88. PubMed ID: 16458886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-hit endocrine model of intrinsic adult-onset asthma.
    Atwood CS; Bowen RL
    Ageing Res Rev; 2008 Apr; 7(2):114-25. PubMed ID: 18373959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of botulinum toxin in physical medicine and rehabilitation.
    Cuevas-Trisán RL; Cruz-Jiménez M
    Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma.
    Pelaia G; Renda T; Gallelli L; Vatrella A; Busceti MT; Agati S; Caputi M; Cazzola M; Maselli R; Marsico SA
    Respir Med; 2008 Aug; 102(8):1173-81. PubMed ID: 18579364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes.
    Anderson SD; Kippelen P
    J Allergy Clin Immunol; 2008 Aug; 122(2):225-35; quiz 236-7. PubMed ID: 18554705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
    Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.